Dr Chun Yew Fong

Clinician Scientist
Acute Leukaemia and Myelodysplasia Lead, Austin Health

Acute leukaemia and myelodysplasia are amongst the most aggressive cancers that we treat. I am passionate about improving the lives of patients dealing with these life-changing cancers through the implementation of new technologies and novel treatments, whilst also delivering compassionate clinical care.

I am a clinical haematologist and the Medical Lead for Acute Leukaemias and Myelodysplasia at the Olivia Newton John Cancer and Wellness Centre, which is based at Austin Health. I share a dual role within ONJCRI as a Clinician Scientist Fellow and am also the Myeloid/Acute Leukaemia Tumour Group Chair for Clinical Trials Australia.

My current role focuses on the implementation of new technologies in translational research and novel therapeutic approaches in the clinic. In particular, I am the lead investigator on clinical trials exploring the implementation of epigenetic-targeted therapies in acute leukaemia. I am also involved in developing next generation sequencing technologies for routine clinical use in tracking minimal residual disease in leukaemia patients.

Following completion of dual physician and pathology clinical training in Melbourne, I embarked upon scientific training at Cambridge University and completed a PhD at Melbourne University which investigated epigenetic therapies. I have been intimately involved in the pre-clinical and clinical development of BET inhibitors and have been published in Nature, Blood, Leukemia & Lymphoma.